Chemokines: A key driver for inflammation in protozoan infection

References

• Fletcher SM, Stark D, Harkness J, et al. Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev. 2012;25(3):420–449. doi:10.1128/CMR.05038-11.
   PubMed Web of Science ®Google Scholar
• Burgess SL, Gilchrist CA, Lynn TC, et al. Parasitic protozoa and interactions with the host intestinal microbiota. Infect Immun. 2017;85(8):e00101–17. doi:10.1128/IAI.00101-17.
   PubMed Web of Science ®Google Scholar
• World Health Organization. World Malaria Report 2021.Geneva: World Health Organization; 2021.
   Google Scholar
• Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients- a review. Mem Inst Oswaldo Cruz. 2002;97(4):443–457. doi:10.1590/s0074-02762002000400001.
   PubMed Web of Science ®Google Scholar
• Kataria P, Surela N, Chaudhary A, et al. MiRNA: Biological regulator in host-parasite interaction during malaria infection. Int J Environ Res Public Health. 2022;19(4):2395. doi:10.3390/ijerph19042395.
   PubMed Web of Science ®Google Scholar
• Osman M, El Safadi D, Cian A, et al. Prevalence and risk factors for intestinal protozoan infections with cryptosporidium, giardia, blastocystis and dientamoeba among schoolchildren in Tripoli, Lebanon. PLoS Negl Trop Dis. 2016;10(3):e0004496. doi:10.1371/journal.pntd.0004496.
   PubMed Web of Science ®Google Scholar
• Nicholson LB. The immune system. Essays Biochem. 2016;60(3):275–301. doi:10.1042/EBC20160017.
   PubMed Web of Science ®Google Scholar
• Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S3–S23. doi:10.1016/j.jaci.2009.12.980.
   PubMed Web of Science ®Google Scholar
• Sokol CL, Luster AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol. 2015;7(5):a016303. doi:10.1101/cshperspect.a016303.
   PubMed Web of Science ®Google Scholar
• Kohli K, Pillarisetty VG, Kim TS. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 2022;29(1):10–21. doi:10.1038/s41417-021-00303-x.
   PubMed Web of Science ®Google Scholar
• Michlmayr D, Lim JK. Chemokine receptors as important regulators of pathogenesis during arboviral encephalitis. Front Cell Neurosci. 2014;8:264. doi:10.3389/fncel.2014.00264.
   PubMed Web of Science ®Google Scholar
• Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 2002;18(6):262–265. doi:10.1016/s1471-4922(02)02283-3.
   PubMed Web of Science ®Google Scholar
• White G, Iqbal A, Greaves D. CC chemokine receptors and chronic inflammation–therapeutic opportunities and pharmacological challenges. Pharmacol Rev. 2013;65(1):47–89. doi:10.1124/pr.111.005074.
   PubMed Web of Science ®Google Scholar
• Kraemer L, McKay DM, Russo RC, et al. Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis. Cytokine Growth Factor Rev. 2022;66:38–52. doi:10.1016/j.cytogfr.2022.05.002.
   PubMed Web of Science ®Google Scholar
• Seed JR. Protozoa: Pathogenesis and defenses. In: S. Baron, ed. Medical microbiology. Galveston, TX: University of Texas Medical Branch at Galveston Copyright © 1996, The University of Texas Medical Branch at Galveston; 1996
   Google Scholar
• Arsić-Arsenijević V, et al. Characteristics of the immune response in protozoan infections. Med Pregl. 2003;56(11-12):557–563.
   PubMedGoogle Scholar
• Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. Febs J. 2018;285(16):2944–2971. doi:10.1111/febs.14466.
   PubMed Web of Science ®Google Scholar
• Villegas-Mendez A, Greig R, Shaw TN, et al. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol. 2012;189(2):968–979. doi:10.4049/jimmunol.1200688.
   PubMed Web of Science ®Google Scholar
• Ponte-Sucre A. An overview of trypanosoma brucei infections: an intense host-parasite interaction. Front Microbiol. 2016;7:2126. doi:10.3389/fmicb.2016.02126.
   PubMed Web of Science ®Google Scholar
• Reid MB, Li Y-P. Tumor necrosis factor-α and muscle wasting: a cellular perspective. Respir Res. 2001;2(5):269–272. doi:10.1186/rr67.
   PubMed Web of Science ®Google Scholar
• Song X, Wei W, Cheng W, et al. Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment. Front Cell Infect Microbiol. 2022;12:939532. doi:10.3389/fcimb.2022.939532.
   PubMed Web of Science ®Google Scholar
• Roggero E, Piazzon I, Nepomnaschy I, et al. Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL/6 mice is partly reverted by lipopolysaccharide pretreatment. FEMS Immunol Med Microbiol. 2004;41(2):123–131. doi:10.1016/j.femsim.2004.02.003.
   PubMedGoogle Scholar
• Niu X, Wang H, Fu ZF. Role of chemokines in rabies pathogenesis and protection. Adv Virus Res. 2011;79:73–89. doi:10.1016/B978-0-12-387040-7.00005-6
   Google Scholar
• McColl SR. Chemokines and dendritic cells: a crucial alliance. Immunol Cell Biol. 2002;80(5):489–496. doi:10.1046/j.1440-1711.2002.01113.x.
   PubMed Web of Science ®Google Scholar
• Rostène W, Kitabgi P, Parsadaniantz SM. Chemokines: a new class of neuromodulator? Nat Rev Neurosci. 2007;8(11):895–903. doi:10.1038/nrn2255.
   PubMed Web of Science ®Google Scholar
• Mélik-Parsadaniantz S, Rostène W. Chemokines and neuromodulation. J Neuroimmunol. 2008;198(1-2):62–68. doi:10.1016/j.jneuroim.2008.04.022.
   PubMed Web of Science ®Google Scholar
• Perpiñá-Viciano C, Işbilir A, Zarca A, et al. Kinetic analysis of the early signaling steps of the human chemokine receptor CXCR4. Mol Pharmacol. 2020;98(2):72–87. doi:10.1124/mol.119.118448.
   Google Scholar
• Wong MM, Fish EN. Chemokines: attractive mediators of the immune response. Semin Immunol. 2003;15(1):5–14. doi:10.1016/s1044-5323(02)00123-9.
   PubMed Web of Science ®Google Scholar
• Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun. 2010;34(1):45–54. doi:10.1016/j.jaut.2009.07.011.
   PubMed Web of Science ®Google Scholar
• Chen K, Bao Z, Tang P, et al. Chemokines in homeostasis and diseases. Cell Mol Immunol. 2018;15(4):324–334. doi:10.1038/cmi.2017.134.
   PubMed Web of Science ®Google Scholar
• Raz E, Mahabaleshwar H. Chemokine signaling in embryonic cell migration: a fisheye view. Development. 2009;136(8):1223–1229. doi:10.1242/dev.022418.
   PubMed Web of Science ®Google Scholar
• Williams JL, Holman DW, Klein RS. Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. Front Cell Neurosci. 2014;8:154. doi:10.3389/fncel.2014.00154.
   PubMed Web of Science ®Google Scholar
• Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;54(5):859–874. doi:10.1016/j.immuni.2021.01.012.
   PubMed Web of Science ®Google Scholar
• Rajagopalan L, Rajarathnam K. Structural basis of chemokine receptor function–a model for binding affinity and ligand selectivity. Biosci Rep. 2006;26(5):325–339. doi:10.1007/s10540-006-9025-9.
   PubMed Web of Science ®Google Scholar
• Bird S, Tafalla C. Teleost chemokines and their receptors. Biology (Basel). 2015;4(4):756–784. doi:10.3390/biology4040756.
   PubMedGoogle Scholar
• Ulvmar MH, Hub E, Rot A. Atypical chemokine receptors. Exp Cell Res. 2011;317(5):556–568. doi:10.1016/j.yexcr.2011.01.012.
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Graham GJ. Atypical chemokine receptors and their roles in the resolution of the inflammatory response. Front Immunol. 2016;7:224. doi:10.3389/fimmu.2016.00224.
   PubMed Web of Science ®Google Scholar
• Nibbs RJ, Graham GJ. Immune regulation by atypical chemokine receptors. Nat Rev Immunol. 2013;13(11):815–829. doi:10.1038/nri3544.
   PubMed Web of Science ®Google Scholar
• Bussmann J, Raz E. Chemokine-guided cell migration and motility in zebrafish development. Embo J. 2015;34(10):1309–1318. doi:10.15252/embj.201490105.
   PubMed Web of Science ®Google Scholar
• Stone MJ, et al. Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. 2017;18(2):342. doi:10.3390/ijms18020342.
   PubMed Web of Science ®Google Scholar
• Malet-Engra G, Yu W, Oldani A, et al. Collective cell motility promotes chemotactic prowess and resistance to chemorepulsion. Curr Biol. 2015;25(2):242–250. doi:10.1016/j.cub.2014.11.030.
   PubMed Web of Science ®Google Scholar
• Tharp WG, Yadav R, Irimia D, et al. Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo. J Leukoc Biol. 2006;79(3):539–554. doi:10.1189/jlb.0905516.
   PubMed Web of Science ®Google Scholar
• Poznansky MC, Olszak IT, Foxall R, et al. Active movement of T cells away from a chemokine. Nat Med. 2000;6(5):543–548. doi:10.1038/75022.
   PubMed Web of Science ®Google Scholar
• Poznansky MC, Olszak IT, Evans RH, et al. Thymocyte emigration is mediated by active movement away from stroma-derived factors. J Clin Invest. 2002;109(8):1101–1110. doi:10.1172/JCI0213853.
   PubMed Web of Science ®Google Scholar
• López-Cotarelo P, Gómez-Moreira C, Criado-García O, et al. Beyond chemoattraction: Multifunctionality of chemokine receptors in leukocytes. Trends Immunol. 2017;38(12):927–941. doi:10.1016/j.it.2017.08.004.
   PubMed Web of Science ®Google Scholar
• Le Y, et al. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol. 2004;1(2):95–104.
   PubMed Web of Science ®Google Scholar
• Tang P, Wang JM. Chemokines: the past, the present and the future. Cell Mol Immunol. 2018;15(4):295–298. doi:10.1038/cmi.2018.9.
   PubMed Web of Science ®Google Scholar
• Russo RC, Garcia CC, Teixeira MM, et al. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593–619. doi:10.1586/1744666X.2014.894886.
   PubMed Web of Science ®Google Scholar
• Wolf M, Moser B. Antimicrobial activities of chemokines: Not just a side-effect? Front Immunol. 2012;3:213. doi:10.3389/fimmu.2012.00213.
   PubMed Web of Science ®Google Scholar
• Mitroulis I, Alexaki VI, Kourtzelis I, et al. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther. 2015;147:123–135. doi:10.1016/j.pharmthera.2014.11.008.
   PubMed Web of Science ®Google Scholar
• Hyun YM, Lefort CT, Kim M. Leukocyte integrins and their ligand interactions. Immunol Res. 2009;45(2-3):195–208. doi:10.1007/s12026-009-8101-1.
   PubMed Web of Science ®Google Scholar
• Dixit N, Simon SI. Chemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrest. Front Immunol. 2012;3:188. doi:10.3389/fimmu.2012.00188.
   PubMed Web of Science ®Google Scholar
• Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013;2013:480739–480720. doi:10.1155/2013/480739.
   PubMed Web of Science ®Google Scholar
• Lira SA, Furtado GC. The biology of chemokines and their receptors. Immunol Res. 2012;54(1-3):111–120. doi:10.1007/s12026-012-8313-7.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Burdick MD, Gomperts BN, et al. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 2005;16(6):593–609. doi:10.1016/j.cytogfr.2005.04.007.
   PubMed Web of Science ®Google Scholar
• Kalyanaraman M, Heidemann SM, Sarnaik AP. Macrophage inflammatory protein-2 predicts acute lung injury in endotoxemia. J Investig Med. 1998;46(6):275–278.
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313–326. doi:10.1089/jir.2008.0027.
   PubMed Web of Science ®Google Scholar
• Rojas-López AE, Soldevila G, Meza-Pérez S, et al. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis. Immunobiology. 2012;217(8):795–807. doi:10.1016/j.imbio.2012.04.005.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Petri WA. Learning from the research on amebiasis and gut microbiome: Is stimulation by gut flora essential for effective neutrophil mediated protection from external pathogens? Gut Microbes. 2019;10(1):100–104. doi:10.1080/19490976.2018.1479626.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Gilchrist CA, Uddin MJ, et al. Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis. PLoS Pathog. 2017;13(8):e1006513. doi:10.1371/journal.ppat.1006513.
   PubMed Web of Science ®Google Scholar
• Lantier L, Lacroix-Lamandé S, Potiron L, et al. Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice. PLoS Pathog. 2013;9(12):e1003801. doi:10.1371/journal.ppat.1003801.
   PubMed Web of Science ®Google Scholar
• Wang H-C, Dann SM, Okhuysen PC, et al. High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect Immun. 2007;75(1):481–487.
   PubMed Web of Science ®Google Scholar
• Crawford CK, Kol A. The mucosal innate immune response to cryptosporidium parvum, a global one health issue. Front Cell Infect Microbiol. 2021;11:689401. doi:10.3389/fcimb.2021.689401.
   PubMed Web of Science ®Google Scholar
• Guesdon W, Auray G, Pezier T, et al. CCL20 displays antimicrobial activity against cryptosporidium parvum, but its expression is reduced during infection in the intestine of neonatal mice. J Infect Dis. 2015;212(8):1332–1340. doi:10.1093/infdis/jiv206.
   PubMed Web of Science ®Google Scholar
• Pantenburg B, Dann SM, Wang H-C, et al. Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun. 2008;76(1):23–29. doi:10.1128/IAI.00960-07.
   PubMed Web of Science ®Google Scholar
• Ritter U, Moll H, Laskay T, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis. 1996;173(3):699–709. doi:10.1093/infdis/173.3.699.
   PubMed Web of Science ®Google Scholar
• Reis MLC, Ferreira VM, Zhang X, et al. Murine immune response induced by Leishmania major during the implantation of paraffin tablets. Virchows Arch. 2010;457(5):609–618. doi:10.1007/s00428-010-0974-9.
   PubMed Web of Science ®Google Scholar
• Conrad SM, Strauss-Ayali D, Field AE, et al. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages. Infect Immun. 2007;75(2):653–665. doi:10.1128/IAI.01314-06.
   PubMed Web of Science ®Google Scholar
• Ritter U, Moll H. Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. Eur J Immunol. 2000;30(11):3111–3120. doi:10.1002/1521-4141(200011)30:11<3111::AID-IMMU3111>3.0.CO;2-O.
   PubMed Web of Science ®Google Scholar
• Santiago HdC, Oliveira CF, Santiago L, et al. Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun. 2004;72(8):4918–4923. doi:10.1128/IAI.72.8.4918-4923.2004.
   PubMed Web of Science ®Google Scholar
• Oghumu S, Lezama-Dávila CM, Isaac-Márquez AP, et al. Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol. 2010;126(3):389–396. doi:10.1016/j.exppara.2010.02.010.
   PubMed Web of Science ®Google Scholar
• Vester B, Müller K, Solbach W, et al. Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun. 1999;67(6):3155–3159. doi:10.1128/IAI.67.6.3155-3159.1999.
   PubMed Web of Science ®Google Scholar
• Steigerwald M, Moll H. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infect Immun. 2005;73(4):2564–2567. doi:10.1128/IAI.73.4.2564-2567.2005.
   PubMed Web of Science ®Google Scholar
• Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22(1):891–928. doi:10.1146/annurev.immunol.22.012703.104543.
   PubMedGoogle Scholar
• Ato M, Nakano H, Kakiuchi T, et al. Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21/19. J Immunol. 2004;173(8):4815–4820. doi:10.4049/jimmunol.173.8.4815.
   PubMed Web of Science ®Google Scholar
• Ato M, Stäger S, Engwerda CR, et al. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol. 2002;3(12):1185–1191. doi:10.1038/ni861.
   PubMed Web of Science ®Google Scholar
• Engwerda CR, Ato M, Cotterell SEJ, et al. A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol. 2002;161(2):429–437. doi:10.1016/s0002-9440(10)64199-5.
   PubMed Web of Science ®Google Scholar
• Engwerda CR, Ato M, Kaye PM. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol. 2004;20(11):524–530. doi:10.1016/j.pt.2004.08.009.
   PubMed Web of Science ®Google Scholar
• Awasthi A, Mathur RK, Saha B. Immune response to Leishmania infection. Indian J Med Res. 2004;119(6):238–258.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Ghosh S, Dasgupta B, et al. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis. 2002;185(12):1704–1708. doi:10.1086/340820.
   PubMed Web of Science ®Google Scholar
• Brandonisio O, Panaro MA, Fumarola I, et al. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med. 2002;2(3):125–129. doi:10.1007/s102380200017.
   PubMed Web of Science ®Google Scholar
• Dey R, Majumder N, Bhattacharyya Majumdar S, et al. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Scand J Immunol. 2007;66(6):671–683. doi:10.1111/j.1365-3083.2007.02025.x.
   PubMed Web of Science ®Google Scholar
• Dey R, Sarkar A, Majumder N, et al. Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis. Infect Immun. 2005;73(12):8334–8344. doi:10.1128/IAI.73.12.8334-8344.2005.
   PubMed Web of Science ®Google Scholar
• Sponaas A-M, Freitas do Rosario AP, Voisine C, et al. Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood. 2009;114(27):5522–5531. doi:10.1182/blood-2009-04-217489.
   PubMed Web of Science ®Google Scholar
• Serbina NV, Jia T, Hohl TM, et al. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008;26(1):421–452. doi:10.1146/annurev.immunol.26.021607.090326.
   PubMedGoogle Scholar
• Clark CJ, Phillips RS. Cerebral malaria protection in mice by species-specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain. Parasite Immunol. 2011;33(11):637–641. doi:10.1111/j.1365-3024.2011.01329.x.
   PubMed Web of Science ®Google Scholar
• Garnica MR, Souto JT, Silva JS, et al. Stromal cell derived factor 1 synthesis by spleen cells in rodent malaria, and the effects of in vivo supplementation of SDF-1alpha and CXCR4 receptor blocker. Immunol Lett. 2002;83(1):47–53. doi:10.1016/s0165-2478(02)00067-6.
   PubMed Web of Science ®Google Scholar
• Nie CQ, Bernard NJ, Norman MU, et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009;5(4):e1000369. doi:10.1371/journal.ppat.1000369.
   PubMed Web of Science ®Google Scholar
• Ioannidis LJ, Nie CQ, Hansen DS. The role of chemokines in severe malaria: more than meets the eye. Parasitology. 2014;141(5):602–613. doi:10.1017/S0031182013001984.
   PubMed Web of Science ®Google Scholar
• Wilson NO, Solomon W, Anderson L, et al. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One. 2013;8(4):e60898. doi:10.1371/journal.pone.0060898.
   PubMed Web of Science ®Google Scholar
• Fernandes AAM, Carvalho LJdM, Zanini GM, et al. Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Clin Vaccine Immunol. 2008;15(4):650–658. doi:10.1128/CVI.00475-07.
   PubMedGoogle Scholar
• Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001;22(2):83–87. doi:10.1016/s1471-4906(00)01812-3.
   PubMed Web of Science ®Google Scholar
• Were T, Hittner JB, Ouma C, et al. Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica. 2006;91(10):1396–1399.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Macphail D, Henriquez FL. The role of chemokines and their receptors during protist parasite infections. Parasitology. 2016;143(14):1890–1901. doi:10.1017/S0031182016001694.
   PubMed Web of Science ®Google Scholar
• Khan IA, Thomas SY, Moretto MM, et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2006;2(6):e49. doi:10.1371/journal.ppat.0020049.
   PubMed Web of Science ®Google Scholar
• Khan IA, MacLean JA, Lee FS, et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity. 2000;12(5):483–494. doi:10.1016/s1074-7613(00)80200-9.
   PubMed Web of Science ®Google Scholar
• Brenier-Pinchart MP, Pelloux H, Simon J, et al. Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro. Mol Cell Biochem. 2000;209(1-2):79–87. doi:10.1023/a:1007075701551.
   PubMed Web of Science ®Google Scholar
• Hardison JL, Wrightsman RA, Carpenter PM, et al. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun. 2006;74(1):135–143. doi:10.1128/IAI.74.1.135-143.2006.
   PubMed Web of Science ®Google Scholar
• Marino APMP, Silva AA, Santos PVA, et al. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem Inst Oswaldo Cruz. 2005;100 Suppl 1(suppl 1):93–96. doi:10.1590/s0074-02762005000900015.
   PubMedGoogle Scholar
• Chalmers, R.M., Chapter Eighteen - Entamoeba histolytica. In: S. L. Percival, et al. eds. Microbiology of waterborne diseases. 2nd ed. London: Academic Press; 2014:355–373.
   Google Scholar
• Nichols GL. Protozoa: Entamoeba histolytica. In Y. Motarjemi, ed. Encyclopedia of food safety. Waltham: Academic Press; 2014:31–36.
   Google Scholar
• Costa CAX, Fonseca THS, Oliveira FMS, et al. Influence of inflammation on parasitism and area of experimental amoebic liver abscess: an ­immunohistochemical and morphometric study. Parasit Vectors. 2011;4(1):27. doi:10.1186/1756-3305-4-27.
   PubMedGoogle Scholar
• Fonseca Z, Díaz-Godínez C, Mora N, et al. Entamoeba histolytica induce signaling via Raf/MEK/ERK for neutrophil extracellular trap (NET) formation. Front Cell Infect Microbiol. 2018;8:226. doi:10.3389/fcimb.2018.00226.
   PubMed Web of Science ®Google Scholar
• Eckmann L, Reed SL, Smith JR, et al. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J Clin Invest. 1995;96(3):1269–1279. doi:10.1172/JCI118161.
   PubMed Web of Science ®Google Scholar
• Dickson-Gonzalez SM, de Uribe ML, Rodriguez-Morales AJ. Polymorphonuclear neutrophil infiltration intensity as consequence of Entamoeba histolytica density in amebic colitis. Surg Infect (Larchmt). 2009;10(2):91–97. doi:10.1089/sur.2008.011.
   PubMed Web of Science ®Google Scholar
• Carrero JC, Reyes-López M, Serrano-Luna J, et al. Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. Int J Med Microbiol. 2020;310(1):151358. doi:10.1016/j.ijmm.2019.151358.
   PubMed Web of Science ®Google Scholar
• Bansal D, Ave P, Kerneis S, et al. An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis. PLoS Negl Trop Dis. 2009;3(11):e551. doi:10.1371/journal.pntd.0000551.
   PubMed Web of Science ®Google Scholar
• Leitch GJ, He Q. Cryptosporidiosis-an overview. J Biomed Res. 2012;25(1):1–16. doi:10.1016/S1674-8301(11)60001-8.
   PubMedGoogle Scholar
• Ahmed SA, Karanis P. Cryptosporidium and cryptosporidiosis: The perspective from the gulf countries. Int J Environ Res Public Health. 2020;17(18):6824. doi:10.3390/ijerph17186824.
   PubMed Web of Science ®Google Scholar
• Yang D, Chen Q, Hoover DM, et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol. 2003;74(3):448–455. doi:10.1189/jlb.0103024.
   PubMed Web of Science ®Google Scholar
• Lacroix-Lamandé S, Mancassola R, Auray G, et al. CCR5 is involved in controlling the early stage of Cryptosporidium parvum infection in neonates but is dispensable for parasite elimination. Microbes and Infection. 2008;10(4):390–395. doi:10.1016/j.micinf.2007.12.020.
   PubMed Web of Science ®Google Scholar
• Campbell LD, Stewart JN, Mead JR. Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice. J Parasitol. 2002;88(5):1014–1016. doi:10.1645/0022-3395(2002)088[1014:STCPII]2.0.CO;2.
   PubMed Web of Science ®Google Scholar
• Wheeler RJ, Gluenz E, Gull K. The cell cycle of Leishmania: morphogenetic events and their implications for parasite biology. Mol Microbiol. 2011;79(3):647–662. doi:10.1111/j.1365-2958.2010.07479.x.
   PubMed Web of Science ®Google Scholar
• Hernández-Bojorge SE, Blass-Alfaro GG, Rickloff MA, et al. Epidemiology of cutaneous and mucocutaneous leishmaniasis in Nicaragua. Parasite Epidemiol Control. 2020;11:e00192. doi:10.1016/j.parepi.2020.e00192.
   PubMedGoogle Scholar
• Schlein Y, Jacobson RL, Messer G. Leishmania infections damage the feeding mechanism of the sandfly vector and implement parasite transmission by bite. Proc Natl Acad Sci USA. 1992;89(20):9944–9948. doi:10.1073/pnas.89.20.9944.
   PubMed Web of Science ®Google Scholar
• Costa-da-Silva AC, et al. Immune responses in leishmaniasis: An overview. Trop Med Infect Dis. 2022;7(4):54. doi:10.3390/tropicalmed7040054.
   PubMedGoogle Scholar
• Yasmin H, Adhikary A, Al-Ahdal MN, et al. Host–pathogen interaction in leishmaniasis: immune response and vaccination strategies. Immuno. 2022;2(1):218–254. doi:10.3390/immuno2010015.
   Google Scholar
• Volpedo G, Pacheco-Fernandez T, Holcomb EA, et al. Mechanisms of immunopathogenesis in cutaneous leishmaniasis and post kala-azar dermal leishmaniasis (PKDL). Front Cell Infect Microbiol. 2021;11:685296. doi:10.3389/fcimb.2021.685296.
   PubMed Web of Science ®Google Scholar
• Bandeira Ferreira FL, Séguin O, Descoteaux A, et al. Persistent cutaneous leishmania major infection promotes infection-adapted myelopoiesis. Microorganisms. 2022;10(3):535. doi:10.3390/microorganisms10030535.
   PubMed Web of Science ®Google Scholar
• Yorek MS, Poudel B, Mazgaeen L, et al. Leishmania major degrades murine CXCL1 - An immune evasion strategy. PLoS Negl Trop Dis. 2019;13(7):e0007533. doi:10.1371/journal.pntd.0007533.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Gomes FL, Sacks D. The influence of early neutrophil-Leishmania interactions on the host immune response to infection. Front Cell Infect Microbiol. 2012;2:59. doi:10.3389/fcimb.2012.00059.
   PubMed Web of Science ®Google Scholar
• Rabhi I, Rabhi S, Ben-Othman R, et al. Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite. BMC Genomics. 2013;14(1):723. doi:10.1186/1471-2164-14-723.
   PubMedGoogle Scholar
• Elmahallawy EK, Alkhaldi AAM, Saleh AA. Host immune response against leishmaniasis and parasite persistence strategies: a review and assessment of recent research. Biomed Pharmacother. 2021;139:111671. doi:10.1016/j.biopha.2021.111671.
   PubMed Web of Science ®Google Scholar
• Brenier-Pinchart MP, Pelloux H, Derouich-Guergour D, et al. Chemokines in host-protozoan-parasite interactions. Trends Parasitol. 2001;17(6):292–296. doi:10.1016/s1471-4922(01)01902-x.
   PubMed Web of Science ®Google Scholar
• Eufrásio de Figueiredo WM, Heredia FF, Santos AS, et al. CXCL10 treatment promotes reduction of IL-10+ regulatory T (Foxp3+ and Tr1) cells in the spleen of BALB/c mice infected by Leishmania infantum. Exp Parasitol. 2019;207:107789. doi:10.1016/j.exppara.2019.107789.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Dey R, Majumder N, et al. A novel approach to regulate experimental visceral leishmaniasis in murine macrophages using CCR5 siRNA. Scand J Immunol. 2008;67(4):345–353.
   PubMed Web of Science ®Google Scholar
• Sato S. Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021;40(1):1. doi:10.1186/s40101-020-00251-9.
   PubMed Web of Science ®Google Scholar
• Scholar E. Malaria, in xPharm: the comprehensive pharmacology reference. S. J. Enna and D. B. Bylund, eds. Elsevier: New York; 2007:1–5.
   Google Scholar
• Awasthi V, Gupta Y, Chauhan R, et al. Growth inhibition of plasmodium falciparum by Nano-molar concentrations of 1-(4‑hydroxy-3-methoxyphenyl) decan-3-one (6-paradol); is a cure at hand? Phytomedicine Plus. 2022;2(1):100208. doi:10.1016/j.phyplu.2021.100208.
   Google Scholar
• Hopp CS, Sinnis P. The innate and adaptive response to mosquito saliva and Plasmodium sporozoites in the skin. Ann N Y Acad Sci. 2015;1342(1):37–43. doi:10.1111/nyas.12661.
   PubMedGoogle Scholar
• Kwapong SS, Asare KK, Kusi KA, et al. Mosquito bites and stage-specific antibody responses against Plasmodium falciparum in southern Ghana. Malar J. 2023;22(1):126. doi:10.1186/s12936-023-04557-8.
   PubMedGoogle Scholar
• Chaudhary A, Kataria P, Surela N, et al. Pathophysiology of cerebral malaria: implications of MSCs as a regenerative medicinal tool. Bioengineering (Basel). 2022;9(6):263. doi:10.3390/bioengineering9060263.
   PubMedGoogle Scholar
• Belachew EB. Immune response and evasion mechanisms of plasmodium falciparum parasites. J Immunol Res. 2018;2018:6529681–6529686. doi:10.1155/2018/6529681.
   PubMed Web of Science ®Google Scholar
• Gonzales SJ, Reyes RA, Braddom AE, et al. Naturally acquired humoral immunity against plasmodium falciparum malaria. Front Immunol. 2020;11:594653. doi:10.3389/fimmu.2020.594653.
   PubMed Web of Science ®Google Scholar
• Chauhan R, Awasthi V, Thakur RS, et al. CD4(+)ICOS(+)Foxp3(+): a sub-population of regulatory T cells contribute to malaria pathogenesis. Malar J. 2022;21(1):32. doi:10.1186/s12936-022-04055-3.
   PubMed Web of Science ®Google Scholar
• Chauhan R, et al. CD4 + ICOS + Foxp3 + regulatory T cells: a novel sub-population associated with pathogenesis of malaria. Current Overview on Disease and Health Research. 2023;9:109–126.
   Google Scholar
• King T, Lamb T. Interferon-γ: the Jekyll and hyde of malaria. PLoS Pathog. 2015;11(10):e1005118. doi:10.1371/journal.ppat.1005118.
   PubMed Web of Science ®Google Scholar
• Gowda NM, Wu X, Gowda DC. TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J Immunol. 2012;188(10):5073–5085. doi:10.4049/jimmunol.1102143.
   PubMed Web of Science ®Google Scholar
• Awasthi V, et al. Effect of L-arginine on the growth of Plasmodium falciparum and immune modulation of host cells. Journal of Vector Borne Diseases. 2017;54(2):139–145.
   PubMed Web of Science ®Google Scholar
• Iwalokun BA, Bamiro SB, Ogunledun A. Levels and interactions of plasma xanthine oxidase, catalase and liver function parameters in Nigerian children with Plasmodium falciparum infection. APMIS. 2006;114(12):842–850. doi:10.1111/j.1600-0463.2006.apm_457.x.
   PubMed Web of Science ®Google Scholar
• Ty MC, Zuniga M, Götz A, et al. Malaria inflammation by xanthine oxidase-produced reactive oxygen species. EMBO Mol Med. 2019;11(8):e9903. doi:10.15252/emmm.201809903.
   PubMed Web of Science ®Google Scholar
• Awasthi V, Chauhan R, Das J. Administration of L-citrulline prevents Plasmodium growth by inhibiting/modulating T-regulatory cells during malaria pathogenesis. J Vector Borne Dis. 2022;59(1):45–51. doi:10.4103/0972-9062.325640.
   PubMed Web of Science ®Google Scholar
• Pollenus E, Pham T-T, Vandermosten L, et al. CCR2 is dispensable for disease resolution but required for the restoration of leukocyte homeostasis upon experimental malaria-associated acute respiratory distress syndrome. Front Immunol. 2020;11:628643. doi:10.3389/fimmu.2020.628643.
   PubMed Web of Science ®Google Scholar
• Belnoue E, Costa FTM, Vigário AM, et al. Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun. 2003;71(6):3648–3651. doi:10.1128/IAI.71.6.3648-3651.2003.
   PubMed Web of Science ®Google Scholar
• van der Heyde HC, Batchelder JM, Sandor M, et al. Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria. Infect Immun. 2006;74(5):2717–2725. doi:10.1128/IAI.00539-10.
   PubMedGoogle Scholar
• Hojo-Souza NS, Pereira DB, de Souza FSH, et al. On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease. Malar J. 2017;16(1):42. doi:10.1186/s12936-017-1683-5.
   PubMedGoogle Scholar
• Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta. 2010;411(21-22):1570–1579. doi:10.1016/j.cca.2010.07.006.
   PubMed Web of Science ®Google Scholar
• Biswas P, Delfanti F, Bernasconi S, et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 1998;91(1):258–265. doi:10.1182/blood.V91.1.258.
   PubMed Web of Science ®Google Scholar
• Liu M, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22(3):121–130.
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25(1):821–852. doi:10.1146/annurev.immunol.25.022106.141557.
   PubMed Web of Science ®Google Scholar
• Armah HB, Wilson NO, Sarfo BY, et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J. 2007;6(1):147. doi:10.1186/1475-2875-6-147.
   PubMedGoogle Scholar
• Jain V, Singh PP, Silawat N, et al. A preliminary study on pro- and anti-inflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India. Acta Trop. 2010;113(3):263–268. doi:10.1016/j.actatropica.2009.11.009.
   PubMed Web of Science ®Google Scholar
• Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491. doi:10.3389/fimmu.2014.00491.
   PubMed Web of Science ®Google Scholar
• Ajioka JW, Morrissette NS. A century of Toxoplasma research. Int J Parasitol. 2009;39(8):859–860. doi:10.1016/j.ijpara.2009.02.006.
   PubMed Web of Science ®Google Scholar
• Ferguson DJ. Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore. Mem Inst Oswaldo Cruz. 2009;104(2):133–148. doi:10.1590/s0074-02762009000200003.
   PubMed Web of Science ®Google Scholar
• Shapiro K, Bahia-Oliveira L, Dixon B, et al. Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food. Food Waterborne Parasitol. 2019;15:e00049. doi:10.1016/j.fawpar.2019.e00049.
   PubMedGoogle Scholar
• Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634–640. doi:10.1046/j.1469-0691.2002.00485.x.
   PubMed Web of Science ®Google Scholar
• Aliberti J, Valenzuela JG, Carruthers VB, et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol. 2003;4(5):485–490. doi:10.1038/ni915.
   PubMed Web of Science ®Google Scholar
• Ibrahim HM, Xuan X, Nishikawa Y. Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells. Clin Vaccine Immunol. 2010;17(9):1322–1329. doi:10.1128/CVI.00128-10.
   PubMedGoogle Scholar
• Ibrahim HM, Bannai H, Xuan X, et al. Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces Bradyzoite conversion in a CCR5-dependent manner. Infect Immun. 2009;77(9):3686–3695. doi:10.1128/IAI.00361-09.
   PubMed Web of Science ®Google Scholar
• Ibrahim HM, Nishimura M, Tanaka S, et al. Overproduction of Toxoplasma gondii cyclophilin-18 regulates host cell migration and enhances parasite dissemination in a CCR5-independent manner. BMC Microbiol. 2014;14(1):76. doi:10.1186/1471-2180-14-76.
   PubMedGoogle Scholar
• Halonen SK, Taylor GA, Weiss LM. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun. 2001;69(9):5573–5576. doi:10.1128/IAI.69.9.5573-5576.2001.
   PubMed Web of Science ®Google Scholar
• Baral TN. Immunobiology of African trypanosomes: need of alternative interventions. J Biomed Biotechnol. 2010;2010:389153–389124. doi:10.1155/2010/389153.
   PubMedGoogle Scholar
• Onyilagha C, Uzonna JE. Host immune responses and immune evasion strategies in african trypanosomiasis. Front Immunol. 2019;10:2738. doi:10.3389/fimmu.2019.02738.
   PubMed Web of Science ®Google Scholar
• Kuzoe FA. Current situation of African trypanosomiasis. Acta Trop. 1993;54(3-4):153–162. doi:10.1016/0001-706x(93)90089-t.
   PubMed Web of Science ®Google Scholar
• Aliberti JC, Machado FS, Gazzinelli RT, et al. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun. 1999;67(6):2810–2814. doi:10.1128/IAI.67.6.2810-2814.1999.
   PubMed Web of Science ®Google Scholar
• Noël W, Hassanzadeh G, Raes G, et al. Infection Stage-Dependent Modulation of Macrophage Activation in Trypanosoma congolense-Resistant and -Susceptible Mice. Infect Immun. 2002;70(11):6180–6187. doi:10.1128/IAI.70.11.6180-6187.2002.
   PubMed Web of Science ®Google Scholar
• Bachelerie F, Ben-Baruch A, Burkhardt AM, et al. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2014;66(1):1–79. doi:10.1124/pr.113.007724.
   PubMed Web of Science ®Google Scholar
• Graham GJ, Locati M, Mantovani A, et al. The biochemistry and biology of the atypical chemokine receptors. Immunol Lett. 2012;145(1-2):30–38. doi:10.1016/j.imlet.2012.04.004.
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, et al. The major glycoprotein of the Duffy blood-group antigen (Gpd), which is the malarial Plasmodium-vivax erythrocyte receptor is also a novel class of chemokine receptor and is present in brain, kidney, lung, thymus, and spleen. Faseb J. 1994.
   Web of Science ®Google Scholar
• Kima P, Soong L. Interferon gamma in leishmaniasis. Front Immunol. 2013;4:156. doi:10.3389/fimmu.2013.00156.
   PubMed Web of Science ®Google Scholar
• Hoge J, Yan I, Jänner N, et al. IL-6 controls the innate immune response against listeria monocytogenes via classical IL-6 Signaling. J Immunol. 2013;190(2):703–711. doi:10.4049/jimmunol.1201044.
   PubMed Web of Science ®Google Scholar
• Dunst J, Kamena F, Matuschewski K. Cytokines and chemokines in cerebral malaria pathogenesis. Front Cell Infect Microbiol. 2017;7:324. doi:10.3389/fcimb.2017.00324.
   PubMed Web of Science ®Google Scholar
• Amezcua Vesely MC, Rodríguez C, Gruppi A, et al. Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans. Biochim Biophys Acta Mol Basis Dis. 2020;1866(5):165706. doi:10.1016/j.bbadis.2020.165706.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–686. doi:10.1016/j.it.2004.09.015.
   PubMed Web of Science ®Google Scholar
• Politz O, Kodelja V, Guillot P, et al. Pseudoexons and regulatory elements in the genomic sequence of the β-chemokine, alternative macrophage activation-associated cc-chemokine (AMAC)-1. Cytokine. 2000;12(2):120–126. doi:10.1006/cyto.1999.0538.
   PubMed Web of Science ®Google Scholar
• Qi W, Chen X, Polhill TS, et al. TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol. 2006;290(3):F703–9. doi:10.1152/ajprenal.00254.2005.
   PubMed Web of Science ®Google Scholar